Amrita School of Biotechnology currently looked to licence out its newly-developed technologies like sensors and glucose trip pumping device to private distributors. “We are negotiating with companies and have not decided on the pricing for the insulin pump. Our goal is to keep the cost at 1/10th of the insulin pumps available today,” said Bipin Nair, professor &dean, Amrita School of Biotechnology.